Medical devices, healthcare technology and the business of care
510(k) clearance · K260470

Electronic Blood Pressure Monitor (BP-204C, BP-204A, BP-215, BP-203C, BP-205A, BP-201C, BP-217, BP-202C, BP-202 BP-205, BP-205B,BP-206)

Shenzhen Brav Electronic Technologies Co., Ltd. · Decision date Oct 1, 2026

MEDTECHLEDGER EXPLANATIONK260470

What did the FDA decide?

Shenzhen Brav Electronic Technologies Co., Ltd. received a substantially equivalent (SESE) decision for K260470, an Electronic Blood Pressure Monitor listed under model designations BP-204C, BP-204A, BP-215, BP-203C, BP-205A, BP-201C, BP-217, BP-202C, BP-202, BP-205, BP-205B and BP-206. The FDA recorded the decision on 2026-10-01 for a traditional 510(k) received 02/12/2026, classified under regulation 870.1130 with product code DXN in the Cardiovascular specialty and review panel. SESE denotes clearance of the premarket notification, not PMA approval.

The public record does not state which model or component was the subject of any change, nor does it identify a predicate device, so the specific comparison underlying the equivalence finding is unknown. The listing also shows the application was not reviewed by a third party, is not a combination product, and has no authorized predetermined change control plan. No clinical performance data, labeling, or indications for use appear in the available material.

Readers should treat this as a dated regulatory status record only. Any inference about measurement accuracy, intended patient population, or legal scope of clearance would require the underlying FDA decision documents, which were not provided here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 1, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260470
Regulatory pathway
510(k) premarket notification
Product code
DXN
Decision code
SESE
Decision date
Oct 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Measurement, Blood-Pressure, Non-Invasive.

Product code
DXN
FDA device class
2

FDA decision timeline

  1. K260470 received

    Application receipt date recorded by FDA.

  2. K260470 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DXN

Product / regulatory recordCompanyPathwayDecision dateSource
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.510(k) clearanceOct 28, 2026FDA
OMRON Healthcare, Inc.510(k) clearanceSep 10, 2026FDA
Happy Health, Inc.510(k) clearanceSep 3, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Shenzhen Brav Electronic Technologies Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shenzhen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records